{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:52:33Z","timestamp":1786989153501,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.fertnstert.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T09:00:25Z","timestamp":1496394025000},"page":"152-160.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study"],"prefix":"10.1016","volume":"108","author":[{"given":"David F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita I.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Lukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine D.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-8236","authenticated-orcid":false,"given":"Jingjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juki W.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Chwalisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM199303253281207","article-title":"Indications for hysterectomy","volume":"328","author":"Carlson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"issue":"2 Pt 1","key":"10.1016\/j.fertnstert.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/AOG.0b013e318299a6cf","article-title":"Nationwide trends in the performance of inpatient hysterectomy in the United States","volume":"122","author":"Wright","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2015.03.019","article-title":"The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013","volume":"213","author":"Soliman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib8","series-title":"Lupron Depot 3.75 mg (leuprolide acetate). Full prescribing information","year":"2013"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib9","series-title":"Lupron Depot 11.25 mg (leuprolide acetate). Full prescribing information","year":"2013"},{"issue":"2 Pt 1","key":"10.1016\/j.fertnstert.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/AOG.0b013e31820780e3","article-title":"Uterine leiomyomas: individualizing the approach to a heterogeneous condition","volume":"117","author":"Laughlin","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/whe.15.100","article-title":"Medical management of heavy menstrual bleeding","volume":"12","author":"Maybin","year":"2016","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1210\/jc.2008-1695","article-title":"Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix","volume":"94","author":"Struthers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2016-3845","article-title":"Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women","volume":"102","author":"Ng","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1933719113497292","article-title":"Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study","volume":"21","author":"Diamond","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5301\/je.5000157","article-title":"Elagolix, an oral GnRH antagonist for endometriosis-associated pain: a randomized controlled study","volume":"5","author":"Carr","year":"2013","journal-title":"J Endometr Pelvic Pain Disord"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/1933719114549848","article-title":"Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density","volume":"21","author":"Carr","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5301\/je.5000211","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist: results from a phase 2, randomized controlled study","volume":"7","author":"\u00c1cs","year":"2015","journal-title":"J Endometr Pelvic Pain Disord"},{"issue":"2 Pt 1","key":"10.1016\/j.fertnstert.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/AOG.0b013e3181ca4b3a","article-title":"Quantitative measurements of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transition","volume":"115","author":"Hale","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss\u2013a population study. Variation at different ages and attempts to define normality","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625187.2014.894184","article-title":"Impact of a new levonorgestrel intrauterine system, Levosert, on heavy menstrual bleeding: results of a one-year randomised controlled trial","volume":"19","author":"Mawet","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of menstrual blood loss","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib27","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/03007995.2016.1248382","article-title":"Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire","volume":"33","author":"Coyne","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.whi.2004.07.005","article-title":"Validating a pencil-and-paper measure of perimenopausal menstrual blood loss","volume":"14","author":"Mansfield","year":"2004","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New directions in the epidemiology of uterine fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajog.2010.02.039","article-title":"Racial and ethnic disparities in benign gynecologic conditions and associated surgeries","volume":"202","author":"Jacoby","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1997.37697335150.x","article-title":"Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia","volume":"37","author":"Elizalde","year":"1997","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib35","first-page":"323","article-title":"Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group","volume":"94","author":"Archer","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/01.gme.0000178450.29377.c9","article-title":"Bleeding patterns during continuous estradiol with different sequential progestogens therapy","volume":"12","author":"Di Carlo","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib37","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.05.006_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/aje\/kwp043","article-title":"Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation","volume":"169","author":"Derby","year":"2009","journal-title":"Am J Epidemiol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821730362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821730362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T16:28:11Z","timestamp":1663950491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502821730362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S001502821730362X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.05.006","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}